{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T18:44:49Z","timestamp":1775155489136,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","prd-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism & Related Disorders"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.parkreldis.2014.11.024","type":"journal-article","created":{"date-parts":[[2014,12,4]],"date-time":"2014-12-04T02:45:21Z","timestamp":1417661121000},"page":"199-204","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Reduction of gastrointestinal symptoms in Parkinson's disease after\u00a0a\u00a0switch from oral therapy to rotigotine transdermal patch: A\u00a0non-interventional prospective multicenter trial"],"prefix":"10.1016","volume":"21","author":[{"given":"Dirk","family":"Woitalla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Kassubek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Timmermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Lauterbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reinhard","family":"Berkels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Grieger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2014.11.024_bib1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.parkreldis.2010.08.003","article-title":"Gastrointestinal dysfunction in Parkinson's disease","volume":"17","author":"Pfeiffer","year":"2011","journal-title":"Park Relat Disord"},{"key":"10.1016\/j.parkreldis.2014.11.024_bib2","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.parkreldis.2011.12.004","article-title":"Gastroparesis and Parkinson's disease: a systematic review","volume":"18","author":"Heetun","year":"2012","journal-title":"Park Relat Disord"},{"key":"10.1016\/j.parkreldis.2014.11.024_bib3","series-title":"Neuroanatomy and pathology of sporadic Parkinson's disease","author":"Braak","year":"2009"},{"key":"10.1016\/j.parkreldis.2014.11.024_bib4","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1002\/mds.22643","article-title":"The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease","volume":"24","author":"Barone","year":"2009","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2014.11.024_bib5","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1212\/WNL.37.7.1253","article-title":"Parkinson's disease and megacolon: concentric hyaline inclusions (Lewy bodies) in enteric ganglion cells","volume":"37","author":"Kupsky","year":"1987","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2014.11.024_bib6","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0140-6736(95)92707-7","article-title":"Dopaminergic defect of enteric nervous system in Parkinson's disease patients with chronic constipation","volume":"346","author":"Singaram","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.parkreldis.2014.11.024_bib7","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/BF00294234","article-title":"Parkinson's disease: an immunohistochemical study of Lewy body-containing neurons in the enteric nervous system","volume":"79","author":"Wakabayashi","year":"1990","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.parkreldis.2014.11.024_bib8","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neulet.2005.11.012","article-title":"Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology","volume":"396","author":"Braak","year":"2006","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.parkreldis.2014.11.024_bib9","first-page":"421","article-title":"Is there a delayed gastric emptying of patients with early-stage, untreated Parkinson's disease? An analysis using the 13C-acetate breath test","volume":"258","author":"Tanaka","year":"2011","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.parkreldis.2014.11.024_bib10","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/mds.24921","article-title":"Lewy pathology and neurodegeneration in premotor Parkinson's disease","volume":"27","author":"Del Tredici","year":"2012","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2014.11.024_bib11","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1212\/WNL.0b013e3181c34af5","article-title":"Medical records documentation of constipation preceding Parkinson disease: a case-control study","volume":"73","author":"Savica","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2014.11.024_bib12","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1002\/mds.21560","article-title":"Bowel movement frequency in late-life and incidental Lewy bodies","volume":"22","author":"Abbott","year":"2007","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2014.11.024_bib13","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1523\/JNEUROSCI.4720-05.2006","article-title":"Physiological modulation of intestinal motility by enteric dopaminergic neurons and the D2 receptor: analysis of dopamine receptor expression, location, development, and function in wild-type and knock-out mice","volume":"26","author":"Li","year":"2006","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.parkreldis.2014.11.024_bib14","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/mds.1203","article-title":"Gastric emptying time and gastric motility in patients with Parkinson's disease","volume":"16","author":"Hardoff","year":"2001","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2014.11.024_bib15","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1212\/WNL.46.4.1051","article-title":"Gastric emptying in Parkinson's disease: patients with and without response fluctuations","volume":"46","author":"Djaldetti","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2014.11.024_bib16","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1211\/0022357991772123","article-title":"Characterization of dopamine receptor subtypes involved in experimentally induced gastric and duodenal ulcers in rats","volume":"51","author":"Desai","year":"1999","journal-title":"J\u00a0Pharm Pharmacol"},{"key":"10.1016\/j.parkreldis.2014.11.024_bib17","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/j.1365-2265.1976.tb03876.x","article-title":"Bromocriptine potentiation of gastric acid secretion in cats","volume":"5","author":"Hirst","year":"1976","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.parkreldis.2014.11.024_bib18","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00210-008-0341-4","article-title":"The in\u00a0vitro receptor profile of rotigotine: a new agent for the treatment of Parkinson's disease","volume":"379","author":"Scheller","year":"2009","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.parkreldis.2014.11.024_bib19","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.clinthera.2012.02.008","article-title":"Steady-state plasma concentration profile of transdermal rotigotine: an integrated analysis of three, open-label, randomized, phase I multiple dose studies","volume":"34","author":"Elshoff","year":"2012","journal-title":"Clin Ther"},{"key":"10.1016\/j.parkreldis.2014.11.024_bib20","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1002\/mds.21741","article-title":"Rotigotine transdermal patch in early Parkinson's disease: a randomized, double-blind, controlled study versus placebo and ropinirole","volume":"22","author":"Giladi","year":"2007","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2014.11.024_bib21","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1212\/01.wnl.0000252355.79284.22","article-title":"Randomized, blind, controlled trial of transdermal rotigotine in early Parkinson disease","volume":"68","author":"Watts","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2014.11.024_bib22","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1212\/01.wnl.0000259516.61938.bb","article-title":"Advanced Parkinson disease treated with rotigotine transdermal system: PREFER Study","volume":"68","author":"LeWitt","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2014.11.024_bib23","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S1474-4422(07)70108-4","article-title":"Efficacy of pramipexole and transdermal rotigotine in advanced Parkinson's disease: a double-blind, double-dummy, randomised controlled trial","volume":"6","author":"Poewe","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.parkreldis.2014.11.024_bib24","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/mds.23441","article-title":"Rotigotine effects on early morning motor function and sleep in Parkinson's disease: a double-blind, randomized, placebo-controlled study (RECOVER)","volume":"26","author":"Trenkwalder","year":"2011","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2014.11.024_bib25","series-title":"Neupro\u00ae (Rotigotine transdermal patch). Summary of product characteristics","author":"European Medicines Agency","year":"2013"},{"key":"10.1016\/j.parkreldis.2014.11.024_bib26","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1053\/j.gastro.2006.03.008","article-title":"The functional gastrointestinal disorders and the Rome III process","volume":"130","author":"Drossman","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.parkreldis.2014.11.024_bib27","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/wnf.0b013e318154c7c4","article-title":"Overnight switch from oral dopaminergic agonists to transdermal rotigotine patch in subjects with Parkinson disease","volume":"30","author":"LeWitt","year":"2007","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.parkreldis.2014.11.024_bib28","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/1471-2377-11-100","article-title":"Overnight switch from ropinirole to transdermal rotigotine patch in patients with Parkinson disease","volume":"11","author":"Kim","year":"2011","journal-title":"BMC Neurol"},{"key":"10.1016\/j.parkreldis.2014.11.024_bib29","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1365-2982.2006.00780.x","article-title":"Predictors of gastric emptying in Parkinson's disease","volume":"18","author":"Goetze","year":"2006","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.parkreldis.2014.11.024_bib30","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jns.2011.06.050","article-title":"Treatment approaches of gastrointestinal dysfunction in Parkinson's disease, therapeutical options and future perspectives","volume":"310","author":"Woitalla","year":"2011","journal-title":"J\u00a0Neurol Sci"}],"container-title":["Parkinsonism & Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802014004593?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802014004593?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T07:29:31Z","timestamp":1538033371000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802014004593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S1353802014004593"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2014.11.024","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduction of gastrointestinal symptoms in Parkinson's disease after\u00a0a\u00a0switch from oral therapy to rotigotine transdermal patch: A\u00a0non-interventional prospective multicenter trial","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2014.11.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}